Doctor Deniz Akdis
University Heart Center, Zurich (Switzerland)
Identifying proteomic profiles as indicators of disease severity in arrhythmogenic cardiomyopathy
Event: ESC Congress 2022
Topic: Cellular Mechanisms of Arrhythmias
Session: Arrhythmia mechanisms
Novel plasma biomarkers in arrhythmogenic cardiomyopathy: The role of ST2 and GDF-15 in predicting biventricular involvement
Event: ESC Congress 2020
Topic: Arrhythmogenic Right Ventricular Cardiomyopathy
Session: Ventricular Arrhythmias and Sudden Cardiac Death (SCD) ePosters
Left ventricular dysfunction in arrhythmogenic cardiomyopathy: the influence of genotype, exercise and biomarkers
Event: EHRA 2019
Topic: Arrhythmogenic Right Ventricular Cardiomyopathy
Session: Ventricular Arrhythmias and Sudden Cardiac Death (SCD)
Identification of novel biomarkers for diagnosis of arrhythmogenic right ventricular cardiomyopathy using transcriptomics and label-free proteomics
Event: ESC Congress 2018
Topic: Cardiomyopathies
Session: Novel molecular mechanisms in heart failure
Sex hormones affect outcome in arrhythmogenic right ventricular cardiomyopathy/dysplasia: from a stem cell derived cardiomyocyte-based model to clinical biomarkers of disease outcome
Event: EHRA EUROPACE - CARDIOSTIM 2017
Topic: Clinical mechanisms (Cardiac arrhythmias, non invasive)
Session: Young Investigator Award: Basic and Translational Science
Association between genotype and long-term outcome of ventricular involvement patterns in arrhythmogenic right ventricular cardiomyopathy/dysplasia
Event: EHRA EUROPACE - CARDIOSTIM 2017
Topic: Clinical mechanisms (Cardiac arrhythmias, non invasive)
Session: ECG and eCardiology
Elevated testosterone serum levels contribute to adverse outcome in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia
Event: ESC Congress 2016
Topic: Sudden death / resuscitation
Session: Sudden cardiac death
ESC 365 is supported by
